106 related articles for article (PubMed ID: 11548300)
1. AIDS clinical research for New Yorkers.
GMHC Treat Issues; 2001 May; 15(5):11. PubMed ID: 11548300
[No Abstract] [Full Text] [Related]
2. Vaccines for HIV--Remune returns.
TreatmentUpdate; 2004 Oct; 16(6):3. PubMed ID: 17219678
[No Abstract] [Full Text] [Related]
3. Vaccines. Study finds Remune reduces risk of virologic failure.
TreatmentUpdate; 2004 Oct; 16(6):3-4. PubMed ID: 17225281
[No Abstract] [Full Text] [Related]
4. A new approach: immune-based treatments against HIV.
Berger DS
Posit Aware; 2007; 18(3):43-4. PubMed ID: 17526118
[No Abstract] [Full Text] [Related]
5. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever?
Egan MA
Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741
[No Abstract] [Full Text] [Related]
6. Remune trial will stop; new trials planned.
James JS
AIDS Treat News; 1999 May; (No 319):1-2. PubMed ID: 11366461
[TBL] [Abstract][Full Text] [Related]
7. Trial suggests vaccines could aid HIV therapy.
Check E
Nature; 2003 Apr; 422(6933):650. PubMed ID: 12700722
[No Abstract] [Full Text] [Related]
8. Twenty years of HIV-1 research: what the future holds.
Imami N; Gotch F
Nat Immunol; 2003 Jun; 4(6):501. PubMed ID: 12774067
[No Abstract] [Full Text] [Related]
9. Vaccines. From Brazil and France: a vaccine against HIV may lower viral load.
TreatmentUpdate; 2005; 17(1):10-1. PubMed ID: 17228459
[No Abstract] [Full Text] [Related]
10. In brief: immune based therapies.
Proj Inf Perspect; 1999 Sep; (28):24. PubMed ID: 11367364
[TBL] [Abstract][Full Text] [Related]
11. Remune rejected. (will a manual recount be required?).
Martinez LJ
Res Initiat Treat Action; 2000 Dec; 6(4):23-4. PubMed ID: 11708171
[No Abstract] [Full Text] [Related]
12. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
13. [Immune-based therapies and HIV infection].
Weiss L
Ann Med Interne (Paris); 2002 Jun; 153(4):227-36. PubMed ID: 12218888
[TBL] [Abstract][Full Text] [Related]
14. A look at HIV immune research. Interview by Alan Huff.
Landay A
Res Initiat Treat Action; 2000 Sep; 6(3):30-3. PubMed ID: 11708165
[No Abstract] [Full Text] [Related]
15. Anti-HIV agents. Receptor blocker (SCH 532706) enters clinical trials.
TreatmentUpdate; 2008 Mar; 20(2):8-9. PubMed ID: 18663778
[No Abstract] [Full Text] [Related]
16. Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).
Boström AC; Hejdeman B; Matsuda R; Fredriksson M; Fredriksson EL; Bratt G; Sandström E; Wahren B
Vaccine; 2004 Apr; 22(13-14):1683-91. PubMed ID: 15068851
[TBL] [Abstract][Full Text] [Related]
17. Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.
Jacobson JM; Pat Bucy R; Spritzler J; Saag MS; Eron JJ; Coombs RW; Wang R; Fox L; Johnson VA; Cu-Uvin S; Cohn SE; Mildvan D; O'Neill D; Janik J; Purdue L; O'Connor DK; Vita CD; Frank I;
J Infect Dis; 2006 Sep; 194(5):623-32. PubMed ID: 16897661
[TBL] [Abstract][Full Text] [Related]
18. AIDS-associated Kaposi's sarcoma associated with a low viral load and a high CD4 cell count.
Stebbing J; Powles T; Bower M
AIDS; 2008 Feb; 22(4):551-2. PubMed ID: 18301078
[No Abstract] [Full Text] [Related]
19. Ferrovir: a new antiviral drug for the treatment of HIV.
Nossik D; Kaplina E; Nossik N; Sato S; Fomin Y; Voronin E
Am Clin Lab; 2001; 20(9):36-8. PubMed ID: 11766418
[No Abstract] [Full Text] [Related]
20. Immune-based therapies at the retrovirus conference.
Raymond D
Posit Aware; 2003; 14(3):16-7. PubMed ID: 12866485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
